Methamphetamine and core temperature in the rat: Ambient temperature, dose, and the effect of a D2 receptor blocker

Psychopharmacology

Volumn 228, Issue 4, 2013, Pages 551-561

  Sabol, Karen E ^a   Yancey, Danielle M ^a,b   Speaker, H Anton ^a   Mitchell, Scott L ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Ambient temperature; Core temperature; D2 receptor; Methamphetamine; Raclopride

Indexed keywords

DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; RACLOPRIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; COOLING; CORE TEMPERATURE; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; DRUG EFFECT; ENVIRONMENTAL TEMPERATURE; HYPERTHERMIA; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPERATURE DEPENDENCE; TEMPERATURE SENSITIVITY; THERMODYNAMICS; THERMOREGULATION;

ANIMALS; BODY TEMPERATURE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; HYPOTHERMIA; MALE; METHAMPHETAMINE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TEMPERATURE;

EID: 84881257758     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3059-z     Document Type: Article

References (42)

1. Aman TK, Shen RY, Haj-Dahmane S (2007) D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance. J Pharmacol Exp Ther 320:376-385
2. Andersen PH (1988) Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146:113-120
3. Bowyer JF, Gough B, Slikker W, Lipe GW, Newport GD, Holson RR (1993) Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav 44:87-98
4. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580
5. Broderick PA, Piercey MF (1998) Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. J Neural Transm 105:749-767
6. Broening HW, Morford LL, Vorhees CV (2005) Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 56:84-93
7. Bronstein DM, Hong JS (1995) Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality. J Pharmacol Exp Ther 274:943-950
8. Dafters RI, Lynch E (1998) Persistent loss of thermoregulaton in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) but not by fenfluramine. Psychopharmacology 138:207-212
9. de Wit H, Clark M, Brauer LH (1997) Effects of d-amphetamine in grouped versus isolated humans. Pharmacol Biochem Behav 57:333-340
10. Dewar KM, Montreuil B, Grondin L, Reader TA (1989) Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J Pharmacol Exp Ther 250:696-706
11. Docherty JR, Green AR (2010) The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. Br J Pharmacol 160:1029-1044
12. Eltayb A, Lindblom S, Oerther S, Ahlenius S (2001) Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat. Acta Physiol Scand 172:205-209
13. Faunt JE, Crocker AD (1987) The effects of selective dopamine receptor agonists and antagonists on body temperature in rats. Eur J Pharmacol 133:243-7
14. Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38:339-344
15. Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H (1999) Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacology 142:41-50
16. Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391-403
17. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
18. Hansen MG, Whishaw IQ (1973) The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat. Psychopharmacologia 29:33-44
19. Ishigami A, Kubo S, Gotohda T, Tokunaga I (2003) The application of immunohistochemical findings in the diagnosis in methamphetamine-related death-two forensic autopsy cases. J Med Invest 50:112-116
20. Kiyatkin EA, Brown PL (2005) Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats. Eur J Neurosci 22:930-938
21. Kohler C, Hall H, Ogren SO, Gawell L (1985) Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259
22. Lee TF, Mora F, Myers RD (1985) Dopamine and thermoregulation: an evaluation with special reference to dopaminergic pathways. Neurosci Biobehav Rev 9:589-598
23. Malmberg A, Jackson DM, Eriksson A, Mohell N (1993) Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol 43:749-754
24. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
25. Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL (1998) S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. J Pharmacol Exp Ther 287:167-186
26. Morrison SF, Nakamura K (2011) Central neural pathways for thermoregulation. Front Biosci 16:74-104
27. Myles BM, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat - part 2: an escalating regimen. Psychopharmacology 198:313-322
28. Myles BM, Jarrett LA, Broom SL, Speaker HA, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat - part 1: chronic treatment and ambient temperature. Psychopharmacology 198:301-311
29. Nakamura K, Morrison SF (2007) Central efferent pathways mediating skin cooling-evoked sympathetic thermogenesis in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 292:R127-R136
30. Nakazato T, Horikawa HP, Akiyama A (1998) The dopamine D2 receptor antagonist sulpiride causes long-lasting serotonin release. Eur J Pharmacol 363:29-34
31. Newman-Tancredi A, Heusler P, Martel J, Ormiere A, Leduc N, Cussac D (2008) Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells. Int J Neuropsychopharmacol 11:293-307
32. Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I (2007) Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 572:120-128
33. Ootsuka Y, Heidbreder CA, Hagan JJ, Blessing WW (2007) Dopamine D2 receptor stimulation inhibits cold-initiated thermogenesis in brown adipose tissue in conscious rats. Neuroscience 147:127-135
34. Phelps G, Speaker HA, Sabol KE (2010) Relationship between methamphetamine-induced behavioral activation and hyperthermia. Brain Res 1357:41-52
35. Romanovsky AA (2007) Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 292:R37-R46
36. Rusyniak DE, Ootsuka Y, Blessing WW (2008) When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists. Neuroscience 154:1619-1626
37. Sabol KE, Richards JB, Broom SL, Roach JT, Hausknecht KA, Myles BM (2001) Long-term effects of high-dose methamphetamine on reaction time in the rat. Brain Res 892:122-129
38. Salmi P, Jimenez P, Ahlenius S (1993) Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 236:395-400
39. Sugimoto Y, Ohkura M, Inoue K, Yamada J (2001) Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice. Eur J Pharmacol 430:265-268
40. Suresh PS, Punde RR, Gupta M, Dixit A, Giri S, Rajagopal S, Mullangi R (2011) A highly sensitive LC-MS/MS method for the determination of S-raclopride in rat plasma: application to a pharmacokinetic study in rats. Biochem Chromatogr 25:930-937
41. Yehuda S, Wurtman RJ (1972) The effects of d-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci I 11:851-859
42. Zysk JR, Widzowski D, Sygowski LA, Knappenberger KS, Spear N, Elmore CS, Dorff P, Liu H, Doherty J, Chhajlani V (2011) Absence of direct effects on the dopamine D2 receptor by mGluR2/3-selective receptor agonists LY 354,740 and LY 379,268. Synapse 65:64-68